2025-04-08 18:25:27
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Nath Bio-Genes Ltd Q2 FY2024 consolidated PAT up YoY at Rs. 2.03 crore
Posted On : 2023-10-16 23:02:26( TIMEZONE : IST )
Nath Bio-Genes (India) Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 22.5677 crores during the period ended September 30, 2023 as compared to Rs. 235.2816 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 2.0337 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 33.4032 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 0.86 for the period ended September 30, 2023 as compared to Rs. 17.59 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 22.5677 crs | ₹235.2816 crs |  -90.41% |
| Net Profit | ₹2.0337 crs | ₹33.4032 crs | -93.91% |
| EPS | ₹0.86 | ₹17.59 | -95.11% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 22.5677 crores during the period ended September 30, 2023 as compared to Rs.21.7289 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.2.0337 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.1.4693 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.0.86 for the period ended September 30, 2023 as compared to Rs.0.77 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 22.5677 crs | ₹21.7289 crs |  3.86% |
| Net Profit | ₹2.0337 crs | ₹1.4693 crs | 38.41% |
| EPS | ₹0.86 | ₹0.77 | 11.69% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.257.8493 crores during the 6 Months period ended September 30, 2023 as compared to Rs.231.0788 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.35.1054 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.32.2257 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.18.27 for the 6 Months period ended September 30, 2023 as compared to Rs.16.96 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹257.8493 crs | ₹231.0788 crs | 11.59% |
| Net Profit | ₹35.1054 crs | ₹32.2257 crs | 8.94% |
| EPS | ₹18.27 | ₹16.96 | 7.72% |
Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 218.75 as compared to the previous close of Rs. 214.95. The total number of shares traded during the day was 5314 in over 410 trades.
The stock hit an intraday high of Rs. 222.00 and intraday low of 214.00. The net turnover during the day was Rs. 1163275.00.
